MedTrace Logo

Falls: A Marker of Preclinical AD

NCT04949529 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 355

Last updated 2026-07-22

Study results available
· View outcomes & findings →

Summary

This longitudinal cohort study investigates cognitively normal participants with and without preclinical Alzheimer disease (AD) in order to examine: (1) the relationship between falls and functional mobility in preclinical stages of AD; and (2) a hypothesized model of central and peripheral mechanism(s) underlying falls and functional mobility in preclinical stages of AD.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Susan L Stark, PhD · Washington University School of Medicine

  • Beau Ances, MD, PhD, MSc · Washington University School of Medicine

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-07
Primary Completion
2025-04-30
Completion
2025-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04949529 on ClinicalTrials.gov